BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 30922965)

  • 1. PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway.
    Bai Y; Liu X; Qi X; Liu X; Peng F; Li H; Fu H; Pei S; Chen L; Chi X; Zhang L; Zhu X; Song Y; Wang Y; Meng S; Jiang T; Shao S
    EBioMedicine; 2019 Apr; 42():311-325. PubMed ID: 30922965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAP kinase-interacting serine/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer.
    Guo Z; Peng G; Li E; Xi S; Zhang Y; Li Y; Lin X; Li G; Wu Q; He J
    Sci Rep; 2017 Sep; 7(1):10612. PubMed ID: 28878291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycyrrhetinic acid induces cytoprotective autophagy via the inositol-requiring enzyme 1α-c-Jun N-terminal kinase cascade in non-small cell lung cancer cells.
    Tang ZH; Zhang LL; Li T; Lu JH; Ma DL; Leung CH; Chen XP; Jiang HL; Wang YT; Lu JJ
    Oncotarget; 2015 Dec; 6(41):43911-26. PubMed ID: 26549806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside metabolite compound K induces apoptosis and autophagy in non-small cell lung cancer cells via AMPK-mTOR and JNK pathways.
    Li C; Dong Y; Wang L; Xu G; Yang Q; Tang X; Qiao Y; Cong Z
    Biochem Cell Biol; 2019 Aug; 97(4):406-414. PubMed ID: 30475650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
    Wang Z; Ma B; Li H; Xiao X; Zhou W; Liu F; Zhang B; Zhu M; Yang Q; Zeng Y; Sun Y; Sun S; Wang Y; Zhang Y; Weng H; Chen L; Ye M; An X; Liu J
    Oncotarget; 2016 Jan; 7(1):509-23. PubMed ID: 26575790
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Wang K; Chen B; Yin T; Zhan Y; Lu Y; Zhang Y; Chen J; Wu W; Zhou S; Mao W; Tan Y; Du B; Liu X; Ho HI; Xiao J
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway.
    Lu L; Liu Q; Wang P; Wu Y; Liu X; Weng C; Fang X; Li B; Cao X; Mao H; Wang L; Guan M; Wang W; Liu G
    BMC Cancer; 2019 Mar; 19(1):209. PubMed ID: 30849960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SOX2/PDIA6 axis mediates aerobic glycolysis to promote stemness in non-small cell lung cancer cells.
    Wan X; Ma D; Song G; Tang L; Jiang X; Tian Y; Yi Z; Jiang C; Jin Y; Hu A; Bai Y
    J Bioenerg Biomembr; 2024 Jun; 56(3):323-332. PubMed ID: 38441855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
    Kao SJ; Lee WJ; Chang JH; Chow JM; Chung CL; Hung WY; Chien MH
    Environ Toxicol; 2017 Apr; 32(4):1426-1438. PubMed ID: 27539140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erlotinib induces the human non-small-cell lung cancer cells apoptosis via activating ROS-dependent JNK pathways.
    Shan F; Shao Z; Jiang S; Cheng Z
    Cancer Med; 2016 Nov; 5(11):3166-3175. PubMed ID: 27726288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
    Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
    Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
    Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z
    J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phanginin R Induces Cytoprotective Autophagy via JNK/c-Jun Signaling Pathway in Non-Small Cell Lung Cancer A549 Cells.
    Zhang LL; Bao H; Xu YL; Jiang XM; Li W; Zou L; Lin LG; Lu JJ
    Anticancer Agents Med Chem; 2020; 20(8):982-988. PubMed ID: 32286950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptotagmin 7 in twist-related protein 1-mediated epithelial - Mesenchymal transition of non-small cell lung cancer.
    Liu X; Li C; Yang Y; Liu X; Li R; Zhang M; Yin Y; Qu Y
    EBioMedicine; 2019 Aug; 46():42-53. PubMed ID: 31395502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer.
    Qian Y; Pei D; Cheng T; Wu C; Pu X; Chen X; Liu Y; Shen H; Zhang W; Shu Y
    Med Oncol; 2015 Mar; 32(3):44. PubMed ID: 25631633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROCK1 knockdown inhibits non-small-cell lung cancer progression by activating the LATS2-JNK signaling pathway.
    Xin T; Lv W; Liu D; Jing Y; Hu F
    Aging (Albany NY); 2020 Jun; 12(12):12160-12174. PubMed ID: 32554853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis.
    Chen L; Han X; Hu Z; Chen L
    Cancer Chemother Pharmacol; 2019 May; 83(5):921-931. PubMed ID: 30859368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
    Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK
    Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
    Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.